Merck's release on the first day of operations after completing its merger with Schering-Plough.
WHITEHOUSE STATION, N.J. – November 4, 2009 – Merck & Co., Inc. (NYSE: MRK) today outlined its global plans following the completion of Merck's merger with Schering-Plough Corporation announced yesterday.
Merck's release on the first day of operations after completing its merger with Schering-Plough. Company press release, read in the Internet Archive capture of merck.com dated 2009-12-08 (the live merck.com URL has since moved). Related SEC record: joint press release of 2009-11-03 filed as Exhibit 99.1, https://www.sec.gov/Archives/edgar/data/310158/000119312509223917/dex991.htm. Merck's animal-health unit was then named Intervet/Schering-Plough Animal Health and later Merck Animal Health; the FDA sponsor of record remains Intervet, Inc. (see FBB-14, FBB-15, FBB-19). Context: Schering-Plough owned Intervet and the Panacur/Safe-Guard fenbendazole business; this made Merck Animal Health the current owner. Study type: news.
